In this issue:
Economics of lung cancer screening:
- Cost of screening in Australia
- Cost effectiveness of screening in the US
- Cost of screening in Denmark
PD-L1 expression and pembrolizumab outcomes in NSCLC
PROFILE 1001: crizotinib in ROS1-rearranged NSCLC
CASPIAN: durvalumab in SCLC
Lung cancer stigma
New technologies in lung cancer:
- Microwave ablation and brachytherapy for NSCLC
- Confocal laser endomicroscopy guidance for pleural biopsies
- STELLAR: Tumour Treating Fields in malignant pleural mesothelioma
Please login below to download this issue (PDF)